15
S.O.D. - The Impact of Late Diagnosis Rebecca Mayers RGN RSCN Paediatric Endocrine Nurse Specialist Great Ormond Street Hospital NHS Trust

S.O.D. - The Impact of Late Diagnosis

  • Upload
    nerita

  • View
    26

  • Download
    0

Embed Size (px)

DESCRIPTION

S.O.D. - The Impact of Late Diagnosis. Rebecca Mayers RGN RSCN Paediatric Endocrine Nurse Specialist Great Ormond Street Hospital NHS Trust. Charlotte. NVD 42 weeks 3.76kg SCBU – neonatal hepatitis & ABO incompatible Transfer to KCH London Discharged at one month Under KCH until age 5 - PowerPoint PPT Presentation

Citation preview

Page 1: S.O.D.  - The Impact of Late Diagnosis

S.O.D. - The Impact of Late Diagnosis

Rebecca MayersRGN RSCN

Paediatric Endocrine Nurse SpecialistGreat Ormond Street Hospital NHS Trust

Page 2: S.O.D.  - The Impact of Late Diagnosis

Charlotte NVD 42 weeks 3.76kg SCBU – neonatal hepatitis & ABO

incompatible Transfer to KCH London Discharged at one month Under KCH until age 5 Squint repair Moorfields – March 2006 No allergies, no medications Immunisations up to date

Page 3: S.O.D.  - The Impact of Late Diagnosis

Referral Chronological age 9.696years Mainstream school Physically active Local investigations into short

stature• Hypothyroid FT4=7.2 TSH 2.81• Low cortisols (random) 21, 66• Café au lait spots (? Neurofibromatosis

type1)

Page 4: S.O.D.  - The Impact of Late Diagnosis

Admission Wt 25.6kg (>9th; -0.82) Ht 121cm

(0.4 – 2nd; -2.33 SDS) 24hr cortisol profile Karyotype Thyroid function tests Paired urine/plasma osmolalities MRI brain Glucagon test

Page 5: S.O.D.  - The Impact of Late Diagnosis

Karyotype 46XX,No NF1 gene mutation

TSH 2.7mU/L <6.0FT4 7.2pmol/l 12-22IGF1 15ng/ml 44-167IGFBP-3 0.54mg/l 0.575-20.274Paired osmolality plasma 290mOsm/Kg

Urine 1066mOsm/KgNa 140mmol/l 133-146K 4.6mmol/l 3.5-5.5urea 3.9mmol/l 2.5-6.0creatinine 36mmol/l 35-70GH peak 0.6 mU/L Normal >20

Results

Page 6: S.O.D.  - The Impact of Late Diagnosis

Cortisol ProfileTime Cortisol nmol/L14:00 <2818:00 3220:00 <2822:00 <2800:00 3804:00 10606:00 6408:00 4610:00 31

Page 7: S.O.D.  - The Impact of Late Diagnosis

MRI Ectopic

neurohypophysis with an absent pituitary stalk.

Pituitary gland small. Optic Nerves do not

appear to unite normally in the midline resulting in a wide optic chiasm with a slightly abnormal configuration.

Right optic tract is small

PPOC

AP

Page 8: S.O.D.  - The Impact of Late Diagnosis

Diagnosis Not NF1 Hypopituitarism MRI findings Therefore diagnosed as Septo-Optic

Dysplasia

Page 9: S.O.D.  - The Impact of Late Diagnosis

Septo-Optic Dysplasia Congenital Syndrome Hypoplasia of the optic nerve Hypopituitarism Absence of the septum

pellucidum/hypoplasia or absence of corpus callosum

Varying degrees of the condition

Page 10: S.O.D.  - The Impact of Late Diagnosis

The plan Medications on discharge

Hydrocortisone 5mg/2.5mg/2.5mg Levothyroxine 25mcg Emergency hydrocortisone kit Commenced 0.6mg GH Saizen Easypod

Page 11: S.O.D.  - The Impact of Late Diagnosis

Steroid card

Page 12: S.O.D.  - The Impact of Late Diagnosis

Emergency Injection

Page 13: S.O.D.  - The Impact of Late Diagnosis

Medic Alert

Page 14: S.O.D.  - The Impact of Late Diagnosis

Ongoing issues Age at diagnosis No preceding illness so acceptance

difficult Life changing Questioning the need for the

treatment

Page 15: S.O.D.  - The Impact of Late Diagnosis

References Brook C, Hindmarsh P (2001) Clinical

Paediatric Endocrinology, Blackwel Science Ltd.

Dattani M (2001) Septo-Optic Dysplasia: From Mouse to Man, Clinical Pediatric Endocrinology

Kelberman D, Dattani M (2007) Genetics of Septo-Optic Dysplasia, Pituitary